
Caregivers reported itch, symptom, and QOL gains with roflumilast cream 0.05% in infants with AD; an FDA decision is due February 2027.
This year's roundup looks at innovations in wound care, hand sanitizers, otoscopy, and vision screening. It also considers helpful online resources?and takes a peek into a virtual time capsule of technology.






